Table of Contents
Contributors, ix
Preface, xiv
1 Donor and graft selection strategy, 1Ayman Saad, Marisa B. Marques, and Shin Mineishi
2 HLA typing and implications, 9Bronwen E. Shaw and Stephen R. Spellman
3 Risk-benefit assessment in allogeneic hematopoietic transplant: Factors, scores, and models, 19Mahmoud Elsawy and Mohamed L. Sorror
4 Donor and recipient pre-transplant evaluation, 36Shuang Fu and Navneet S. Majhail
5 Autologous and allogeneic progenitor cell mobilization, 45Racquel D. Innis-Shelton and Luciano J. Costa
6 Hematopoietic stem and progenitor cell collection by apheresis: Techniques and tricks, 53Anand Padmanabhan
7 Hematopoietic cell processing: From procurement to infusion, 59Jay S. Raval, Kathryn McKay, and Yara A. Park
8 Graft manipulation: T-cell depletion and beyond, 66Christina Cho and Miguel-Angel Perales
9 Graft-versus-host disease prophylaxis, 73Melhem Solh and Asad Bashey
10 Acute lymphoblastic leukemia, 80Ghada Zakout and Adele K. Fielding
11 Acute myeloid leukemia, 89Hillard M. Lazarus and Masumi Ueda
12 Myelodysplastic syndromes, 97Melinda Biernacki and H. Joachim Deeg
13 Chronic myelogenous leukemia, 108Daniel Egan and Jerald Radich
14 Philadelphia chromosome negative myeloproliferative neoplasms, 116Nicolaus Kröger
15 Chronic lymphocytic leukemia, 123Fabienne McClanahan Lucas and John Gribben
16 Hodgkin Lymphoma, 131Anna Sureda and Eva Domingo-Domenech
17 Indolent lymphomas, 140Narendranath Epperla, Hamza Hashmi, and Mehdi Hamadani
18 Diffuse large B-cell lymphoma, 151Syed Abbas Ali, Istvan Redei, and Syed A. Abutalib
19 Mantle cell lymphoma, 164Narendranath Epperla and Timothy S. Fenske
20 T-cell lymphoma, 179Adrienne A. Phillips and Koen van Besien
21 Primary CNS lymphoma, 188Henry C. Fung, Philip Pancari, and Patricia Kropf
22 Autologous hematopoietic transplant in multiple myeloma, 194Nisha S. Joseph, Ajay K. Nooka, and Sagar Lonial
23 Allogeneic hematopoietic transplant in multiple myeloma, 207Parameswaran Hari and Binod Dhakal
24 Light-chain amyloidosis, 214Amara S. Hussain and Anita D’Souza
25 Autoimmune disorders, 221Adam Bryant and Harold Atkins
26 Testicular cancer, 229Moshe C. Ornstein, Navneet S. Majhail, and Timothy Gilligan
27 Sickle cell disease, 236Sonali Chaudhury and Shalini Shenoy
28 Hematopoietic cell transplant in thalassemia, 246Emanuele Angelucci and Federica Pilo
29 Fanconi anemia, 255Flore Sicre de Fontbrune, Jean Soulier, and Regis Peffault de Latour
30 Immunodeficiency disorders, 264Jennifer A. Kanakry and Dennis D. Hickstein
31 Inherited metabolic disorders, 272Jaap Jan Boelens and Robert F. Wynn
32 Aplastic anemia and paroxysmal nocturnal hemoglobinuria, 281Andrew C. Dietz and Michael A. Pulsipher
33 HIV infection and transplantation, 290Nitya Nathwani, Stephen J. Forman, and Amrita Krishnan
34 Engraftment and graft failure: Assessment and practical considerations, 297Yogesh Jethava, Madan Jagasia, Mohamed Mohty, and Bipin N. Savani
35 Immune reconstitution and tolerance, 304udovic Belle and William R. Drobyski
36 Donor lymphocyte infusion, 315David C. Halverson and Daniel Fowler
37 Diagnosis and treatment of acute graft-versus-host disease, 324Natasha Kekre and Vincent T. Ho
38 Diagnosis and treatment of chronic graft-versus-host disease, 334Sabarinath Venniyil Radhakrishnan and Daniel R. Couriel
39 Prevention and treatment of infection, 348Corrado Girmenia, Gian Maria Rossolini, and Claudio Viscoli
40 Early non-infectious complications after hematopoietic cell transplantation, 359Piyanuch Kongtim and Stefan O. Ciurea
41 Post-transplant lymphoproliferative disorders, 369Michael D. Keller, Conrad R. Cruz, and Catherine M. Bollard
42 Survivorship issues after transplantation, 376Vanessa E. Kennedy, Madan Jagasia, and Bipin N. Savani
Index, 384